Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Huiying Yang is active.

Publication


Featured researches published by Huiying Yang.


Gastroenterology | 1997

A new syndrome of Crohn's disease and pachydermoperiostosis in a family

Rand F. Compton; William J. Sandborn; Huiying Yang; Noralane M. Lindor; William J. Tremaine; Mark D. P. Davis; Allam A. Khalil; Nikolaos A. Tountas; Dolly B. Tyan; Carol J. Landers; Kent D. Taylor; Thomas R. Viggiano; Eric L. Matteson; Arnold L. Schroeter; Scott E. Plevy; Fabio Cominelli; Stephan R. Targan; Jerome I. Rotter

Few syndromic associations with Crohns disease are described. The aim of this study was to characterize a new syndrome of Crohns disease associated with pachydermoperiostosis in 3 brothers. Three probands, 6 siblings, both parents, 20 of 21 third-generation relatives, and 9 spousal controls were evaluated. Serological evaluation for antineutrophil cytoplasmic antibodies and human leukocyte antigens as well as genetic testing for tumor necrosis factor microsatellites, intercellular adhesion molecule 1 polymorphisms, the interleukin 1 receptor antagonist gene, and the interleukin 1 beta gene were performed. Only the 3 probands were affected and developed pachydermoperiostosis between ages 14 and 17 years. Pachydermoperiostosis preceded Crohns ileocolitis by 6 and 20 years in two probands, excluding secondary hypertrophic osteoarthropathy. Two probands were antineutrophil cytoplasmic antibody positive vs. 1 of 27 unaffected relatives (P < 0.001, chi 2). Haplotypes for human leukocyte antigen and tumor necrosis factor microsatellites were discordant. The probands generation was homozygous for the common allele 1 of the interleukin 1 receptor antagonist and interleukin 1 beta genes. Two probands carried a rare polymorphism of the intercellular adhesion molecule 1 gene. A new syndrome of Crohns disease and pachydermoperiostosis associated with antineutrophil cytoplasmic antibodies is described. Inheritance is most likely autosomal recessive by pedigree. No clear association was found between this syndrome and the gene regions evaluated.


Archive | 2004

Methods of assessing Crohn's disease patient phenotype by I2, OmpC and ASCA serologic response

Stephan R. Targan; Eric A. Vasiliauskas; William S. Mow; Huiying Yang; Phillip Fleshner; Jerome I. Rotter


Archive | 2003

Method of haplotype-based genetic analysis for determining risk for developing insulin resistance, coronary artery disease and other phenotypes

Kent D. Taylor; Jerome I. Rotter; Huiying Yang; Willa A. Hsueh; Xiuqing Guo; Leslie J. Raffel; Mark O. Goodarzi


Archive | 2002

Methods of using a nod2/card15 haplotype to diagnose crohn's disease

Kent D. Taylor; Jerome I. Rotter; Huiying Yang; Kazuhito Sugimura; Stephan R. Targan


Emery and Rimoin's Principles and Practice of Medical Genetics (Sixth Edition) | 2013

Chapter 68 – Inflammatory Bowel Disease

Kent D. Taylor; Huiying Yang; Jerome I. Rotter


Archive | 2004

Verfahren zur beurteilung des phänotyps eines patienten mit morbus crohn über eine serologische i2-, ompc- und asca-reaktion A process for the assessment of the phenotype of a patient with crohn's disease a serological i2, ompC and asca-reactive

Stephan R. Targan; Eric A. Vasiliauskas; William S. Mow; Huiying Yang; Phillip Fleshner; Jerome I. Rotter


Archive | 2004

A method for assessment of the phenotype of a patient with Crohn's disease via a serological i2-, ompC and ASCA-reactive

Stephan R. Targan; Eric A. Vasiliauskas; William S. Mow; Huiying Yang; Phillip Fleshner; Jerome I. Rotter


Archive | 2003

Mutationen in nod2 sind bei patienten mit morbus crohn mit fibrostenosebildung assoziiert Mutations in NOD2 are associated with patients with crohn's disease with fibrostenosebildung

Maria T. Abreu; Kent D. Taylor; Jerome I. Rotter; Huiying Yang; Kazuhito Sugimura; Stephan R. Targan


Archive | 2003

Mutations in NOD2 associated with Crohn's disease patients with fibrostenosebildung

Maria T. Abreu; Kent D. Taylor; Jerome I. Rotter; Huiying Yang; Kazuhito Sugimura; Stephan R. Targan


Archive | 2000

Genetischer test zur bestimmung der nicht-wirksamkeit einer behandlung mit statinmedikamenten Genetic test for the determination of the non-effectiveness of treatment with statin drugs

Jerome I. Rotter; Maren Scheuner; D. Kent Taylor; Huiying Yang

Collaboration


Dive into the Huiying Yang's collaboration.

Top Co-Authors

Avatar

Jerome I. Rotter

Los Angeles Biomedical Research Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Maren Scheuner

Cedars-Sinai Medical Center

View shared research outputs
Top Co-Authors

Avatar

Phillip Fleshner

Cedars-Sinai Medical Center

View shared research outputs
Top Co-Authors

Avatar

William S. Mow

Cedars-Sinai Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge